{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Loracarbef  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Loracarbef. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Loracarbef  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "loracarbef",
    "trial_2_text": "Loracarbef  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Loracarbef Supplement: 60 participants will take Loracarbef 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Loracarbef. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Loracarbef  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.2145659327507019,
      "78": 0.21439577639102936,
      "177": 0.1628035455942154,
      "123": 0.14219233393669128,
      "9": 0.13151876628398895,
      "189": 0.12511540949344635,
      "17": 0.12354236841201782,
      "188": 0.12192969769239426,
      "173": 0.11190210282802582,
      "20": 0.1109294593334198,
      "46": 0.10138601809740067,
      "37": 0.09674327075481415,
      "14": 0.09605581313371658,
      "350": 0.09157050400972366,
      "200": 0.09140919148921967,
      "68": 0.08619565516710281,
      "29": 0.08605170249938965,
      "21": 0.0859096422791481,
      "2": 0.08585508912801743,
      "228": 0.08573085814714432,
      "49": 0.08370620757341385,
      "64": 0.08276727050542831,
      "179": 0.07913344353437424,
      "77": 0.07826779037714005,
      "67": 0.07814984023571014,
      "79": 0.07799778133630753,
      "76": 0.07777347415685654,
      "27": 0.07349062711000443,
      "61": 0.07303304970264435,
      "180": 0.07254458963871002,
      "243": 0.06712573766708374,
      "193": 0.06518889218568802,
      "114": 0.06440719217061996,
      "239": 0.06374849379062653,
      "28": 0.06174135208129883,
      "276": 0.06079331412911415,
      "30": 0.05986309051513672,
      "151": 0.059079382568597794,
      "126": 0.05901087448000908,
      "147": 0.05643584579229355,
      "5": 0.056229136884212494,
      "35": 0.0525834895670414,
      "104": 0.05219483748078346,
      "85": 0.05208565294742584,
      "101": 0.05155892297625542,
      "131": 0.05033079907298088,
      "282": 0.05027332156896591,
      "261": 0.05013512447476387,
      "72": 0.050044529139995575,
      "249": 0.04977165535092354,
      "194": 0.049142930656671524,
      "86": 0.048364441841840744,
      "269": 0.0479622408747673,
      "355": 0.04787641763687134,
      "164": 0.04547790810465813,
      "122": 0.045428212732076645,
      "288": 0.04419548436999321,
      "82": 0.04301352798938751,
      "396": 0.04283541813492775,
      "253": 0.0428197905421257,
      "96": 0.04107442498207092,
      "132": 0.0407290905714035,
      "144": 0.040327660739421844,
      "38": 0.040223877876996994,
      "102": 0.039110321551561356,
      "116": 0.03891540691256523,
      "139": 0.038502052426338196,
      "186": 0.038372211158275604,
      "191": 0.03815852478146553,
      "262": 0.0369284451007843,
      "142": 0.03594394400715828,
      "97": 0.03568179905414581,
      "341": 0.03547004610300064,
      "69": 0.03504050895571709,
      "75": 0.03489542752504349,
      "18": 0.03458636626601219,
      "494": 0.03301849216222763,
      "256": 0.032840795814991,
      "441": 0.03277595713734627,
      "130": 0.03272532671689987,
      "92": 0.03258451074361801,
      "361": 0.0325252003967762,
      "31": 0.03243320435285568,
      "121": 0.03239915519952774,
      "466": 0.03166194632649422,
      "154": 0.031346142292022705,
      "33": 0.031328871846199036,
      "286": 0.031117718666791916,
      "204": 0.03085825964808464,
      "268": 0.030834680423140526,
      "234": 0.03076988086104393,
      "166": 0.02986736409366131,
      "36": 0.029865989461541176,
      "394": 0.029850762337446213,
      "100": 0.02955452911555767,
      "1": 0.02906190976500511,
      "339": 0.028637001290917397,
      "15": 0.028632862493395805,
      "221": 0.02813689224421978,
      "508": 0.02801728993654251
    },
    "trial_2_ae": {
      "87": 0.2145659327507019,
      "78": 0.21439577639102936,
      "177": 0.1628035455942154,
      "123": 0.14219233393669128,
      "9": 0.13151876628398895,
      "189": 0.12511540949344635,
      "17": 0.12354236841201782,
      "188": 0.12192969769239426,
      "173": 0.11190210282802582,
      "20": 0.1109294593334198,
      "46": 0.10138601809740067,
      "37": 0.09674327075481415,
      "14": 0.09605581313371658,
      "350": 0.09157050400972366,
      "200": 0.09140919148921967,
      "68": 0.08619565516710281,
      "29": 0.08605170249938965,
      "21": 0.0859096422791481,
      "2": 0.08585508912801743,
      "228": 0.08573085814714432,
      "49": 0.08370620757341385,
      "64": 0.08276727050542831,
      "179": 0.07913344353437424,
      "77": 0.07826779037714005,
      "67": 0.07814984023571014,
      "79": 0.07799778133630753,
      "76": 0.07777347415685654,
      "27": 0.07349062711000443,
      "61": 0.07303304970264435,
      "180": 0.07254458963871002,
      "243": 0.06712573766708374,
      "193": 0.06518889218568802,
      "114": 0.06440719217061996,
      "239": 0.06374849379062653,
      "28": 0.06174135208129883,
      "276": 0.06079331412911415,
      "30": 0.05986309051513672,
      "151": 0.059079382568597794,
      "126": 0.05901087448000908,
      "147": 0.05643584579229355,
      "5": 0.056229136884212494,
      "35": 0.0525834895670414,
      "104": 0.05219483748078346,
      "85": 0.05208565294742584,
      "101": 0.05155892297625542,
      "131": 0.05033079907298088,
      "282": 0.05027332156896591,
      "261": 0.05013512447476387,
      "72": 0.050044529139995575,
      "249": 0.04977165535092354,
      "194": 0.049142930656671524,
      "86": 0.048364441841840744,
      "269": 0.0479622408747673,
      "355": 0.04787641763687134,
      "164": 0.04547790810465813,
      "122": 0.045428212732076645,
      "288": 0.04419548436999321,
      "82": 0.04301352798938751,
      "396": 0.04283541813492775,
      "253": 0.0428197905421257,
      "96": 0.04107442498207092,
      "132": 0.0407290905714035,
      "144": 0.040327660739421844,
      "38": 0.040223877876996994,
      "102": 0.039110321551561356,
      "116": 0.03891540691256523,
      "139": 0.038502052426338196,
      "186": 0.038372211158275604,
      "191": 0.03815852478146553,
      "262": 0.0369284451007843,
      "142": 0.03594394400715828,
      "97": 0.03568179905414581,
      "341": 0.03547004610300064,
      "69": 0.03504050895571709,
      "75": 0.03489542752504349,
      "18": 0.03458636626601219,
      "494": 0.03301849216222763,
      "256": 0.032840795814991,
      "441": 0.03277595713734627,
      "130": 0.03272532671689987,
      "92": 0.03258451074361801,
      "361": 0.0325252003967762,
      "31": 0.03243320435285568,
      "121": 0.03239915519952774,
      "466": 0.03166194632649422,
      "154": 0.031346142292022705,
      "33": 0.031328871846199036,
      "286": 0.031117718666791916,
      "204": 0.03085825964808464,
      "268": 0.030834680423140526,
      "234": 0.03076988086104393,
      "166": 0.02986736409366131,
      "36": 0.029865989461541176,
      "394": 0.029850762337446213,
      "100": 0.02955452911555767,
      "1": 0.02906190976500511,
      "339": 0.028637001290917397,
      "15": 0.028632862493395805,
      "221": 0.02813689224421978,
      "508": 0.02801728993654251
    }
  },
  "safety": {
    "trial_1_safety": 0.36429399251937866,
    "trial_2_safety": 0.36429399251937866
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.48067551851272583
  }
}